Foster R - Search Results

1

SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.

Duan Z, Bradner JE, Greenberg E, Levine R, Foster R, Mahoney J, Seiden MV. Duan Z, et al. Among authors: foster r. Clin Cancer Res. 2006 Nov 15;12(22):6844-52. doi: 10.1158/1078-0432.CCR-06-1330. Clin Cancer Res. 2006. PMID: 17121906

2

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.

Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Duan Z, et al. Among authors: foster r. Clin Cancer Res. 2006 Sep 1;12(17):5055-63. doi: 10.1158/1078-0432.CCR-06-0861. Clin Cancer Res. 2006. PMID: 16951221

3

8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.

Duan Z, Bradner J, Greenberg E, Mazitschek R, Foster R, Mahoney J, Seiden MV. Duan Z, et al. Among authors: foster r. Mol Pharmacol. 2007 Nov;72(5):1137-45. doi: 10.1124/mol.107.038117. Epub 2007 Aug 3. Mol Pharmacol. 2007. PMID: 17675586

4

GBP1 overexpression is associated with a paclitaxel resistance phenotype.

Duan Z, Foster R, Brakora KA, Yusuf RZ, Seiden MV. Duan Z, et al. Among authors: foster r. Cancer Chemother Pharmacol. 2006 Jan;57(1):25-33. doi: 10.1007/s00280-005-0026-3. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16028104

5

Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT.

Foster R, Solano S, Mahoney J, Fuller A, Oliva E, Seiden MV. Foster R, et al. Gynecol Oncol. 2006 May;101(2):363-6. doi: 10.1016/j.ygyno.2005.12.022. Epub 2006 Jan 24. Gynecol Oncol. 2006. PMID: 16439005

6

Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway.

Chirnomas D, Taniguchi T, de la Vega M, Vaidya AP, Vasserman M, Hartman AR, Kennedy R, Foster R, Mahoney J, Seiden MV, D'Andrea AD. Chirnomas D, et al. Among authors: foster r. Mol Cancer Ther. 2006 Apr;5(4):952-61. doi: 10.1158/1535-7163.MCT-05-0493. Mol Cancer Ther. 2006. PMID: 16648566

7

Mechanisms of Cables 1 gene inactivation in human ovarian cancer development.

Sakamoto H, Friel AM, Wood AW, Guo L, Ilic A, Seiden MV, Chung DC, Lynch MP, Serikawa T, Munro E, Oliva E, Orsulic S, Kirley SD, Foster R, Zukerberg LR, Rueda BR. Sakamoto H, et al. Among authors: foster r. Cancer Biol Ther. 2008 Feb;7(2):180-88. doi: 10.4161/cbt.7.2.5253. Epub 2007 Nov 15. Cancer Biol Ther. 2008. PMID: 18059193 Free article.

8

Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells.

Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E, Scadden DT, Seiden MV, Foster R, Rueda BR. Friel AM, et al. Among authors: foster r. Cell Cycle. 2008 Jan 15;7(2):242-9. doi: 10.4161/cc.7.2.5207. Epub 2007 Oct 24. Cell Cycle. 2008. PMID: 18256549

9

CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.

Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, Foster R. Curley MD, et al. Among authors: foster r. Stem Cells. 2009 Dec;27(12):2875-83. doi: 10.1002/stem.236. Stem Cells. 2009. PMID: 19816957

10

Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.

Gao Y, Foster R, Yang X, Feng Y, Shen JK, Mankin HJ, Hornicek FJ, Amiji MM, Duan Z. Gao Y, et al. Among authors: foster r. Oncotarget. 2015 Apr 20;6(11):9313-26. doi: 10.18632/oncotarget.3220. Oncotarget. 2015. PMID: 25823654 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,400 results

Search Page

Filters